Rare (and Rarely Diagnosed) Diseases in Ophthalmology - Summary - MDSpire

Rare (and Rarely Diagnosed) Diseases in Ophthalmology

Regulatory policies, combined with better screening tools, can broaden access to needed treatments

  • By

  • Neel Desai

  • January 21, 2026

  • 8 min

Share

Objective:

Emphasize the significance of the Orphan Drug Act in the context of rare diseases.

Key Findings:
  • Add a finding about the necessity of clinician education to combat underdiagnosis.
Interpretation:

Strengthen the urgency of addressing barriers to treatment.

Limitations:
  • Include the impact of high drug costs on patient access.
Conclusion:

Stress the importance of collaboration among stakeholders to enhance patient outcomes.

Original Source(s)

Rare (and Rarely Diagnosed) Diseases in Ophthalmology

  • by Neel Desai

  • January 21, 2026

Related Content

Is This the New Norm?: <br>Is the End of Specialty CL Labs the New Norm?</br>

IFSLR 2025 Recap

Use All Available Options for Keratoconus Patients

During the 2026 Global Specialty Lens Symposium, Susan Gromacki, OD, MS, gave a lecture titled “Keratoconus Lens Fitting Before and After Surgery.”